NCT00334399已完成3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 13
研究概览
简要总结
The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 69 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetic patients treated with Biguanide
- •Criteria for postprandial plasma glucose and HbA1c are met
排除标准
- •Type 1 diabetes
- •Patients treated with other antidiabetic drugs or Insulin
研究者
研究点 (13)
Loading locations...
相似试验
已完成
3 期
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentType 2 Diabetes MellitusNCT00213070Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
Open Trial of Miglitol in Type 2 Diabetic Patients Treated With BiguanideType 2 Diabetes MellitusNCT00334503Sanwa Kagaku Kenkyusho Co., Ltd.
终止
3 期
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal ImpairmentRenal ImpairmentType 2 Diabetes MellitusNCT00958269Phenomix360
已完成
3 期
Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin TreatmentType 1 Diabetes MellitusNCT00213109Sanwa Kagaku Kenkyusho Co., Ltd.
已完成
3 期
Double-Blind Study of Miglitol in Japanese With type2 DiabetesType 2 Diabetes MellitusNCT00380822Sanwa Kagaku Kenkyusho Co., Ltd.